InvestorsHub Logo
Followers 32
Posts 2552
Boards Moderated 0
Alias Born 07/16/2006

Re: bladerunner1717 post# 25514

Wednesday, 05/06/2009 8:29:50 PM

Wednesday, May 06, 2009 8:29:50 PM

Post# of 52265
OT
Actually (I've been following this since 1995) the drug was developed by Hoechst, licensed to Titan who did PhII, outlicensed to Novartis, who did the failed PhIII, outlicensed by Novartis to Vanda, who redid PhIII.

As my other post said, maybe it's the akasthisia profile. The Psychiatric Division put Geodon through hell for approval, and nothing went wrong for Geodon users, no real indication of cardiac issue increase. So maybe they decided that this is Geodon with less akasthisia, and might as well be available.

I had posted a Vanda comment immediately after approval on my website, I'm not going to repost it here, because I am getting weary of commenting how wrong I was.

NeuroInvestment
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News